-
1.发明授权USE OF NEOHESPERIDIN DIHYDROCHALCONE FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTING OR TREATING ELEVATED BLOOD LIPID LEVEL-RELATED DISEASES 有权新橙皮苷二氢查耳酮用于生产药物以预防或使用 治疗疾病DUE高血脂肪
公开(公告)号：EP1113726B1
公开(公告)日：2004-03-24
申请号：EP99944890.5
申请日：1999-09-15
发明人： BOK, Song, Hae , JEONG, Tae, Sook , BAE, Ki, Hwan , PARK, Yong, Bok , CHOI, Myung, Sook , MOON, Surk, Sik , KWON, Yong, Kook , LEE, Eun, Sook , HYUN, Byung, Hwa , CHOI, Yang, Kyu , LEE, Chul, Ho , LEE, Sae, Bom , PARK, Young, Bae , KIM, Hyo, Soo
IPC分类号： A23L1/222 , A61K31/35 , A21D13/00 , C07D311/30 , C07H17/07
摘要： A pharmaceutical composition for treating or preventing an elevated blood lipid or glucose level-related disease such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke, hepatic diseases and hyperglycemia in a mammal, which comprises an effective amount of neohesperidin dihydrochalcone as an active ingredient together with a pharmaceutically acceptable carrier, and a functional food or beverage composition for such a disease, which comprises an effective amount of neohesperidin dihydrochalcone.
-
2.发明公开COMPOSITION CONTAINING RUTIN AND QUERCETIN FOR PREVENTING OR TREATING ELEVATED BLOOD LIPID LEVEL-RELATED DISEASES 审中-公开FOR疾病PHOPHYLAXE的治疗和由血压升高FAT MIRROR槲皮素和芦丁，包括成分是由于
公开(公告)号：EP1124564A1
公开(公告)日：2001-08-22
申请号：EP99944892.1
申请日：1999-09-15
发明人： BOK, Song, Hae , JEONG, Tae, Sook , BAE, Ki, Hwan , PARK, Yong, Bok , CHOI, Myung, Sook , MOON, Surk, Sik , KWON, Yong, Kook , LEE, Eun, Sook , HYUN, Byung, Hwa , CHOI, Yang, Kyu , LEE, Chul, Ho , LEE, Sae, Bom , PARK, Young, Bae , KIM, Hyo, Soo
IPC分类号： A61K31/7048 , A23L1/30 , A23L1/302 , A23L2/52 , A61K35/78
CPC分类号： A23L2/52 , A21D2/14 , A23C9/13 , A23C9/152 , A23L7/109 , A23L13/428 , A23L23/00 , A23L27/63 , A61K31/70 , Y10S514/824 , A61K2300/00
摘要： A pharmaceutical composition for treating or preventing an elevated blood lipid level-related disease such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke and hepatic diseases in a mammal, which comprises an effective amount of rutin, quercetin or a mixture thereof as an active ingredient together with a pharmaceutically acceptable carrier, and a food or beverage composition for such a disease, which comprises an effective amount of rutin or quercetin.
-
3.发明公开COMPOSITION CONTAINING NEOHESPERIDIN DIHYDROCHALCONE FOR PREVENTING OR TREATING ELEVATED BLOOD LIPID AND GLUCOSE LEVEL-RELATED DISEASES 有权新橙皮苷二氢查耳酮用于生产药物以预防或使用 治疗疾病DUE高血脂肪
公开(公告)号：EP1113726A1
公开(公告)日：2001-07-11
申请号：EP99944890.5
申请日：1999-09-15
发明人： BOK, Song, Hae , JEONG, Tae, Sook , BAE, Ki, Hwan , PARK, Yong, Bok , CHOI, Myung, Sook , MOON, Surk, Sik , KWON, Yong, Kook , LEE, Eun, Sook , HYUN, Byung, Hwa , CHOI, Yang, Kyu , LEE, Chul, Ho , LEE, Sae, Bom , PARK, Young, Bae , KIM, Hyo, Soo
IPC分类号： A23L1/222 , A61K31/35 , A21D13/00 , C07D311/30 , C07H17/07
摘要： A pharmaceutical composition for treating or preventing an elevated blood lipid or glucose level-related disease such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke, hepatic diseases and hyperglycemia in a mammal, which comprises an effective amount of neohesperidin dihydrochalcone as an active ingredient together with a pharmaceutically acceptable carrier, and a functional food or beverage composition for such a disease, which comprises an effective amount of neohesperidin dihydrochalcone.
-
4.发明公开COMPOSITION CONTAINING NATURAL PHENOLIC COMPOUNDS FOR PREVENTING OR TREATING ELEVATED BLOOD LIPID LEVEL-RELATED DISEASES 审中-公开含组成酚醛自然科学verbindingen防止或 病证治疗引起的血脂ERHOETEM明镜
公开(公告)号：EP1113724A1
公开(公告)日：2001-07-11
申请号：EP99944888.9
申请日：1999-09-15
发明人： BOK, Song , JEONG, Tae , BAE, Ki, Hwan , PARK, Yong, Bok , CHOI, Myung, Sook , MOON, Surk, Sik , KWON, Yong, Kook , LEE, Eun, Sook , HYUN, Byung, Hwa , CHOI, Yang, Kyu , LEE, Chul, Ho , LEE, Sae, Bom , PARK, Young, Bae , KIM, Hyo, Soo
CPC分类号： A23G3/368 , A21D2/14 , A21D2/145 , A21D2/181 , A21D2/36 , A23C9/152 , A23F3/14 , A23L2/56 , A23L33/105 , A61K31/70 , Y10S514/824 , A61K31/35 , A61K31/19 , A61K2300/00
摘要： Elevated blood lipid level-related diseases such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke and hepatic diseases can be effectively treated or prevented by administering a pharmaceutical composition comprising an effective amount of tannin, gallic acid or ellagic acid or by ingesting a functional food or beverage composition comprising an effective amount of tannin, gallic acid or ellagic acid.
-
-
-
搜索结果
4 条记录 (耗时 0.012 秒)
